![Alfredo Zurlo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfredo Zurlo
Inga fler pågående positioner
Profil
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A. Zurlo holds a doctorate degree from The American University of Rome.
Tidigare kända positioner av Alfredo Zurlo
| Företag | Position | Slut |
|---|---|---|
| MOLOGEN AG | Teknisk/Vetenskaplig/F&U Direktör | 2016-03-31 |
| SCANDION ONCOLOGY A/S | Teknisk/Vetenskaplig/F&U Direktör | - |
Glycotope GmbH
 Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Verkställande Direktör | - |
Alfredo Zurlos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
The American University of Rome
 The American University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Glycotope GmbH
Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Technology Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
